Case-Based Subspecialty Review Online Course


This course offers a broad review of cases across 11 subspecialties. Each module addresses one subspecialty and contains 60 minutes of case review and 30 minutes of didactic lecture. The rapid-fire case review will provide an even more comprehensive review of cases with limited differential diagnoses.

In-Training Members will receive a discounted price of $325 after login.  


Target Audience:
The target audience for this activity includes in-training radiologists preparing for exams and active practice, as well as practicing radiologists with an interest in honing their diagnostic skills.

Goals and Objectives:
After completing the material in this activity, the learner should be able to:
  1. Develop differential diagnoses for conditions in 11 radiology subspecialties.
  2. Recognize imaging features that are highly characteristic of a specific diagnosis or diagnostic set.
  3. Recognize the imaging and clinical features that allow for refinement of differential diagnosis, allowing for a more specific diagnosis.
  4. Outline management decisions affecting a variety of commonly encountered clinical scenarios.


Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners’ disclosures:

Planners
  • Angelisa Paladin has nothing to disclose.
  • David Naeger has nothing to disclose.


Speakers

Case-Based Subspecialty Review Module 1: Vascular/Interventional
  • Henry Chou has nothing to disclose.
  • Raja Ramaswamy has nothing to disclose.
  • Davood Abdollahian has nothing to disclose.

Case-Based Subspecialty Review Module 2: Nuclear Medicine
  • William Rieter has nothing to disclose.
  • Phillip Kuo has research grants from Blue Earth Diagnostics and GE Healthcare. Dr. Kuo receives consulting fees form Bayer, Novartis, Konica Minolta, Eisai, and GE Healthcare. Dr. Kuo receives speaking fees from Eisai and is the Senior Medical Director for Konica Minolta.
  • Pradeep Bhambhvani has nothing to disclose.
  • Chirayu Shah has nothing to disclose.

Case-Based Subspecialty Review Module 3: Genitourinary
  • Darcy Wolfman has nothing to disclose.
  • Benjamin Wildman-Tobriner has nothing to disclose.
  • Ania Kielar has nothing to disclose.
  • A.J. Mariano has nothing to disclose.

Case-Based Subspecialty Review Module 4: Gastrointestinal
  • William Masch has nothing to disclose.
  • Sherry Wang has nothing to disclose.
  • Ryan O'Malley has clinical research funding from GE Healthcare.
  • Motoyo Yano has nothing to disclose.

Case-Based Subspecialty Review Module 5: Chest
  • Ahmed El-Sherief has nothing to disclose.
  • David Naeger has nothing to disclose.
  • Girish Shroff has nothing to disclose.
  • Maria Martin has nothing to disclose.

Case-Based Subspecialty Review Module 6: Pediatric
  • David Saul has nothing to disclose.
  • Daniel Rosenbaum has nothing to disclose.
  • Asef Khwaja has nothing to disclose.
  • William McCullough has nothing to disclose.
  • Rahul Nikam has nothing to disclose.

Case-Based Subspecialty Review Module 7: Breast
  • Beatriz Adrada has nothing to disclose.
  • Kirti Kulkarni has nothing to disclose.
  • Jean Kunjummen has nothing to disclose.
  • Haydee Ojeda-Fournier receives consulting fees from IBM and Nannocyte Medical.

Case-Based Subspecialty Review Module 8: Musculoskeletal
  • James Stensby has nothing to disclose.
  • Jonathan Baker has nothing to disclose.
  • Hillary Garner has nothing to disclose.
  • Omer Awan has nothing to disclose.

Case-Based Subspecialty Review Module 9: Cardiac
  • Daniel Vargas has nothing to disclose.
  • Kate Hanneman is a member of the medical advisory board for Sanofi-Genzyme.
  • Demetrios Raptis has nothing to disclose.
  • Laura Jimenez Juan has nothing to disclose.

Case-Based Subspecialty Review Module 10: Ultrasound
  • Peter Wang has nothing to disclose.
  • Anne Kennedy has nothing to disclose.
  • Priyanka Jha has nothing to disclose.
  • Ghaneh Fananapazir has nothing to disclose.

Case-Based Subspecialty Review Module 11: Neuroradiology
  • Margaret Chapman has nothing to disclose.
  • Tabassum Kennedy has nothing to disclose.
  • Kathleen Fink has nothing to disclose.
  • Jennifer Becker has nothing to disclose.


Member Price:
$645.00
NonMember Price:
$895.00

Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Designation Statement
The ARRS designates this educational activity for a maximum of 16.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 16.5 AMA PRA Category 1 Credit(s)™ and 16.5 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Date of issuance: June 1, 2021
Date of expiration: May 31, 2024
Estimated time to complete the activity: 16.5 hour(s)